CTCF and cancer: Further sustaining the view of a tumour suppressive action of CTCF, its loss leads to upregulation of the Programmed Cell Death Protein 1 (PD‐L1) which aids cancer cells to evade immune system surveillance (Martin et al, 2021; Oreskovic et al, 2022).